In healthcare, 3D bioprinting is used to create living human cells or tissue for use in regenerative medicine and tissue engineering.

To strictly manage risks, medical systems usually adopt technologies that matured yesterday. The market promotion of AI innovative technology applications is facing challenges, and relevant regulations must also keep pace with the times.